These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29942764)

  • 1. Fatal pancytopenia due to albendazole treatment for strongyloidiasis.
    Xing F; Ye H; Yang J; Chan JF; Seto WK; Pai PM; Yuen KY; Hung DL
    IDCases; 2018; 12():112-116. PubMed ID: 29942764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disseminated strongyloidiasis successfully treated with extended duration ivermectin combined with albendazole: a case report of intractable strongyloidiasis.
    Pornsuriyasak P; Niticharoenpong K; Sakapibunnan A
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):531-4. PubMed ID: 15689061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases.
    Datry A; Hilmarsdottir I; Mayorga-Sagastume R; Lyagoubi M; Gaxotte P; Biligui S; Chodakewitz J; Neu D; Danis M; Gentilini M
    Trans R Soc Trop Med Hyg; 1994; 88(3):344-5. PubMed ID: 7974685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Death related to albendazole-induced pancytopenia: case report and review.
    Opatrny L; Prichard R; Snell L; Maclean JD
    Am J Trop Med Hyg; 2005 Mar; 72(3):291-4. PubMed ID: 15772324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report: Ivermectin and Albendazole Plasma Concentrations in a Patient with Disseminated Strongyloidiasis on Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy.
    Boodman C; Chhonker YS; Murry DJ; Mah A; Grant J; Steiner T; Libman M; Nishi C; Charles M
    Am J Trop Med Hyg; 2018 Nov; 99(5):1194-1197. PubMed ID: 30226142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.
    Ashida C; Kinoshita K; Nozaki Y; Funauchi M
    BMC Infect Dis; 2020 Jul; 20(1):470. PubMed ID: 32615937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemoptysis in the Immunocompromised Patient: Do Not Forget Strongyloidiasis.
    Shrestha P; O'Neil SE; Taylor BS; Bode-Omoleye O; Anstead GM
    Trop Med Infect Dis; 2019 Feb; 4(1):. PubMed ID: 30759812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A series on intestinal strongyloidiasis in immunocompetent and immunocompromised hosts.
    Ghoshal U; Khanduja S; Chaudhury N; Gangwar D; Ghoshal UC
    Trop Gastroenterol; 2012; 33(2):135-9. PubMed ID: 23025061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fatal case of gram negative bacterial sepsis associated with disseminated strongyloidiasis in an immunocompromised patient.
    Fasih N; Irfan S; Sheikh U; Beg MS
    J Pak Med Assoc; 2008 Feb; 58(2):91-2. PubMed ID: 18333531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperinfection strongyloidiasis in a liver transplant recipient treated with parenteral ivermectin.
    Lichtenberger P; Rosa-Cunha I; Morris M; Nishida S; Akpinar E; Gaitan J; Tzakis A; Doblecki-Lewis S
    Transpl Infect Dis; 2009 Apr; 11(2):137-42. PubMed ID: 19144097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of a single-dose veterinary preparation of ivermectin versus 7-day high-dose albendazole for chronic strongyloidiasis.
    Suputtamongkol Y; Kungpanichkul N; Silpasakorn S; Beeching NJ
    Int J Antimicrob Agents; 2008 Jan; 31(1):46-9. PubMed ID: 18023151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe strongyloidiasis and systemic vasculitis: comorbidity, association or both? Case-based review.
    Miskovic R; Plavsic A; Bolpacic J; Raskovic S; Ranin J; Bogic M
    Rheumatol Int; 2018 Dec; 38(12):2315-2321. PubMed ID: 30353268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic Analysis of the Impact of Overseas and Domestic Treatment and Screening Options for Intestinal Helminth Infection among US-Bound Refugees from Asia.
    Maskery B; Coleman MS; Weinberg M; Zhou W; Rotz L; Klosovsky A; Cantey PT; Fox LM; Cetron MS; Stauffer WM
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004910. PubMed ID: 27509077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Disseminated strongyloidiasis, a rare cause of multiple organ failure].
    Daoudal P; Ribier G; Numeric P; Desbois N; Ramialison C
    Presse Med; 2002 Aug; 31(26):1216-7. PubMed ID: 12212512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated strongyloidiasis complicated by alveolar hemorrhage, meningitis, and septic shock treated with albendazole and subcutaneous ivermectin.
    Balkhair A; Taher HB; Al Busaidi I; Al Amin M; Al-Khirbash A; Al Adawi B; Al-Siyabi T
    Int J Infect Dis; 2019 Sep; 86():44-46. PubMed ID: 31279610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children.
    Marti H; Haji HJ; Savioli L; Chwaya HM; Mgeni AF; Ameir JS; Hatz C
    Am J Trop Med Hyg; 1996 Nov; 55(5):477-81. PubMed ID: 8940976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-Derived Strongyloidiasis Infection in Solid Organ Transplant Recipients: A Review and Pooled Analysis.
    Kim JH; Kim DS; Yoon YK; Sohn JW; Kim MJ
    Transplant Proc; 2016 Sep; 48(7):2442-2449. PubMed ID: 27742318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of strongyloides in Northern Thailand and treatment with ivermectin vs albendazole.
    Nontasut P; Muennoo C; Sa-nguankiat S; Fongsri S; Vichit A
    Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):442-4. PubMed ID: 15916052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of serological follow-up of chronic strongyloidiasis after anthelminthic chemotherapy.
    Page WA; Dempsey K; McCarthy JS
    Trans R Soc Trop Med Hyg; 2006 Nov; 100(11):1056-62. PubMed ID: 16551471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of ivermectin vs. albendazole in the presumptive treatment of strongyloidiasis in immigrants to the United States.
    Muennig P; Pallin D; Challah C; Khan K
    Epidemiol Infect; 2004 Dec; 132(6):1055-63. PubMed ID: 15635962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.